Abstracts

ESTIMATING ATHEROSCLEROTIC RISK IN SOUTH AFRICAN YOUTH WITH PERINATALLY ACQUIRED HIV

Youth living with perinatally acquired HIV infection (YLPHIV) may be at higher risk of atherosclerotic cardiovascular disease (CVD) due to lifetime exposure to HIV and antiretroviral therapy (ART). We determined the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) coronary arteries (CA) and abdominal aorta (AA) risk scores among YLPHIV and HIV-seronegative (HIV-) youth ?15-years of…

PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE VERTICALLY HIV-INFECTED YOUTHS

The prevalence of subclinical liver abnormalities is high among people living with HIV, but data regarding perinatally HIV-infected children and adolescents (PHIV) are scarce. Non-invasive image techniques offer an opportunity to address non-alcoholic fatty liver disease (NAFLD) in a population in which the scores validated for adults have not been tested. Prospective transversal study including…

WEIGHT GAIN AMONG ADOLESCENTS ON DOLUTEGRAVIR: A REAL CONCERN?

Integrase Inhibitors (INI) are now the first-line treatment for people living with HIV, including children. Clinical trials among adults have risen concerns regarding weight gain in patients starting or switching to INI. Clinical trials in children and adolescents are ongoing, as there is concern regarding weight gain in this population, characterized by important changes in…

2-YEAR OUTCOME OF EARLY TREATED INFANTS IN SUB-SAHARAN AFRICA

The real-world evolution of very early treated children born with HIV in high-prevalence settings during first years of life is unclear. We assessed the probability of death, progression to AIDS, viral load (VL) suppression, immunosuppression, and continuation in care of a cohort of early treated children born with HIV. EARTH-EPIICAL Cohort is underway at 2…

HIV-1 RESERVOIR CELL EVOLUTION IN EARLY-TREATED CHILDREN IN BOTSWANA

Despite remarkable advances in prevention of vertical HIV-1 transmission and antiretroviral drug development, pediatric HIV-1 infection remains a frequent and difficult-to-treat disease. Early initiation of antiretroviral therapy (ART) in neonates infected with HIV-1 may limit the frequency and stability of HIV-1 reservoir cells, possibly improving response to interventions aimed at viral eradication and cure. Here,…